Pneumococcal infections at hajj: Current knowledge gaps

Infectious Disorders - Drug Targets

Volumn 14, Issue 3, 2014, Pages 177-184

  Ridda, Iman ^a   King, Catherine ^a   Rashid, Harunor ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

13 valent pneumococcal conjugate vaccine (PCV 13); 23 valent pneumococcal polysaccharide vaccine (PPV 23); Hajj; Invasive pneumococcal disease; Pneumonia

Indexed keywords

PNEUMOCOCCUS VACCINE; 23-VALENT PNEUMOCOCCAL CAPSULAR POLYSACCHARIDE VACCINE; INFLUENZA VACCINE; PREVENAR13;

ARTICLE; HAJJ; HUMAN; IMMUNITY; INFLUENZA; MEDICAL RECORD; NONHUMAN; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLLUTION; SEROTYPE; SMOKING; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TRAVEL; VACCINATION; INFLUENZA, HUMAN; ISLAM; PNEUMOCOCCAL INFECTIONS; RESPIRATORY TRACT INFECTIONS; SAUDI ARABIA; WHOOPING COUGH;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ISLAM; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RESPIRATORY TRACT INFECTIONS; SAUDI ARABIA; SEROGROUP; TRAVEL; VACCINATION; WHOOPING COUGH;

EID: 84928889611     PISSN: 18715265     EISSN: 18755852     Source Type: Journal    
DOI: 10.2174/1871526514666141014150323     Document Type: Article

References (88)

1. Gatrad, A.R.; Sheikh, A. Hajj: journey of a lifetime. B. M. J., 2005, 330 (7483), 133-7.
2. Hanlon, V. Days of the Hajj. C. M. A. J., 2000, 163 (12), 1598-9.
3. Memish, Z.A.; Stephens, G.M.; Steffen, R.; Ahmed, Q.A. Emergence of medicine for mass gatherings: lessons from the Hajj. Lancet Infect. Dis., 2012, 12 (1), 56-65.
4. Memish, Z.A.; Zumla, A.; Alhakeem, R.F.; Assiri, A.; Turkestani, A.; Al Harby, K.D.; Alyemni, M.; Dhafar, K.; Gautret, P.; Barbeschi, M.; McCloskey, B.; Heymann, D.; Al Rabeeah, A.A.; Al- Tawfiq, J.A. Hajj: infectious disease surveillance and control. Lancet, 2014, 383 (9934), 2073-82.
5. Khan, K.; Sears, J.; Hu, V.W.; Brownstein, J.S.; Hay, S.; Kossowsky, D.; Eckhardt, R.; Chim, T.; Berry, I.; Bogoch, I.; Cetron, M. Potential for the international spread of middle East respiratory syndrome in association with mass gatherings in saudi arabia. PLoS Curr., 2013 17, 5.
6. Rashid, H.; Abdul Muttalif, A.R.; Mohamed Dahlan, Z.B.; Djauzi, S.; Iqbal, Z.; Karim, H.M.; Naeem, S.M.; Tantawichien, T.; Zotomayor, R.; Patil, S.; Schmitt, H.J. The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion. Travel Med. Infect. Dis., 2013, 11 (5), 288-94.
7. Pane, M.; Imari, S.; Alwi, Q.; Nyoman Kandun, I.; Cook, A.R.; Samaan, G. Causes of mortality for Indonesian Hajj Pilgrims: comparison between routine death certificate and verbal autopsy findings. PLoS One, 2013, 8 (8), e73243.
8. Alsafadi, H.; Goodwin, W.; Syed, A. Diabetes care during Hajj. Clin. Med., 2011, 11 (3), 218-21.
9. Deris, Z.Z.; Hasan, H.; Ab Wahab, M.S.; Sulaiman, S.A.; Naing, N.N.; Othman, N.H. The association between pre-morbid conditions and respiratory tract manifestations amongst Malaysian Hajj pilgrims. Trop. Biomed., 2010, 27 (2), 294-300.
10. Mirza, T.A.; Fillimban, A.; Maimini, O.; Khiyat, E.Y.; Dhafar, K.O.; Farooq, M.U.; Gazzaz, Z.J. Predictors of asthma severity during the pilgrimage to Mecca (Hajj). Pol. Arch. Med. Wewn., 2011, 121 (10), 327-31.
11. Balaban, V.; Stauffer, W.M.; Hammad, A.; Afgarshe, M.; Abd- Alla, M.; Ahmed, Q.; Memish, Z.A.; Saba, J.; Harton, E.; Palumbo, G.; Marano, N. Protective practices and respiratory illness among US travelers to the 2009 Hajj. J. Travel Med., 2012, 19 (3), 163-8.
12. Al-Jeelani, H.A. Air quality assessment at Al-Taneem area in the Holy Makkah City, Saudi Arabia. Environ. Monit. Assess., 2009, 156 (1-4), 211-22.
13. Hameed, A. Air Contamination at the Holy Mosque. Makkah, Saudi Arabia. CWEJ, 2013, 8 (2), 179-87.
14. Alzeer, A.H. Respiratory tract infection during Hajj. Ann. Thorac. Med., 2009, 4 (2), 50-3.
15. Omar, W. The Mecca pilgrimage; its epidemiological significance and control. Postgrad. Med. J., 1952, 28 (319), 269-74.
16. Farid, M.A. Implications of the Mecca pilgrimage for a regional malaria eradication programme. Bull. World Health Organ., 1956, 15 (3,-5) 828-33.
17. Watson, G.I. Quarantine and the Mecca pilgrimage- the growth of an idea. Trans. R. Soc. Trop. Med. Hyg., 1938,32 (1), 107–12.
18. Memish, Z.; Al Hakeem, R.; Al Neel, O.; Danis, K.; Jasir, A.; Eibach, D. Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011. Euro Surveill., 2013, 18 (37), 20581.
19. Alzahrani, A.G. Pattern of diseases among visitors to Mina health centers during the Hajj season. J. Infect. Public Health, 2012, 5 (1), 22-34.
20. Shakir, H.A. Outpatient Services during (1423h) Hajj Season. Sultan Qaboos Univ. Med. J., 2006, 6 (1), 47-50.
21. Deris, Z.Z. The prevalence of acute respiratory symptoms and role of protective measures among Malaysian hajj pilgrims. J. Travel Med., 2010, 17 (2), 82-8.
22. Al-Ghamdi, S.M.; Akbar, H.O.; Qari, Y.A.; Fathaldin, O.A.; Al- Rashed, R.S. Pattern of admission to hospitals during muslim pilgrimage (Hajj). Saudi Med. J., 2003, 24 (10), 1073-6.
23. Khan, N.A.; Ishag, A.M.; Ahmad, M.S.; El-Sayed, F.M.; Bachal, Z.A.; Abbas, T.G. Pattern of medical diseases and determinants of prognosis of hospitalization during 2005 Muslim pilgrimage Hajj in a tertiary care hospital. A prospective cohort study. Saudi Med. J., 2006, 27 (9), 1373-80.
24. Madani, T.A.; Ghabrah, T.M.; Al-Hedaithy, M.A.; Alhazmi, M.A.; Alazraqi, T.A.; Albarrak, A.M.; Ishaq, A.H. Causes of hospitalization of pilgrims in the Hajj season of the Islamic year 1423 (2003). Ann. Saudi Med., 2006, 26 (5), 346-51.
25. Mandourah, Y.; Al-Radi, A.; Ocheltree, A.H.; Ocheltree, S.R.; Fowler, R.A. Clinical and temporal patterns of severe pneumonia causing critical illness during Hajj. B. M. C. Infect. Dis., 2012, 12, 117.
26. Madani, T.A.; Ghabrah, T.M.; Albarrak, A.M.; Alhazmi, M.A.; Alazraqi, T.A.; Althaqafi, A.O.; Ishaq, A. Causes of admission to intensive care units in the Hajj period of the Islamic year 1424 (2004). Ann. Saudi. Med., 2007, 27 (2), 101-5.
27. Feldman, C.; Abdulkarim, E.; Alattar, F.; Al Lawati, F.; Al Khatib, H.; Al Maslamani, M.; Al Obaidani, I.; Al Salah, M.; Farghaly, M.; Husain, E.H.; Mokadas, E. Pneumococcal disease in the Arabian Gulf: recognizing the challenge and moving toward a solution. J. Infect. Public Health, 2013, 6 (6), 401-9.
28. Memish, Z.A. Microbiology of community-acquired pneumonia in the Gulf Corporation Council states. J. Chemother., 2007, 1, 17-23.
29. Richter, S.S.; Heilmann, K.P.; Dohrn, C.L.; Riahi, F.; Diekema, D.J.; Doern, G.V. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.). Emerg. Infect. Dis., 2013, 19(7), 1074-83.
30. Obaro, S.; Adegbola, R. The pneumococcus: carriage, disease and conjugate vaccines. J. Med. Microbiol., 2002, 51(2), 98-104.
31. Musher, D.M. How contagious are common respiratory tract infections? N. Engl. J. Med., 2003, 348 (13), 1256-66.
32. Bogaert, D.; De Groot, R.; Hermans, P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis., 2004, 4 (3), 144-54.
33. Jacoby, P.; Carville, K.S.; Hall, G.; Riley, T.V.; Bowman, J.; Leach, A.J.; Lehmann, D.; Kalgoorlie Otitis Media Research Project Team. Crowding and other strong predictors of upper respiratory tract carriage of otitis media-related bacteria in Australian Aboriginal and non-Aboriginal children. Pediatr. Infect. Dis. J., 2011, 30 (6), 480-5.
34. Drijkoningen, J.J.; Rohde, G.G. Pneumococcal infection in adults: burden of disease. Clin. Microbiol. Infect., 2014, 5, 45-51.
35. Chidiac, C. Pneumococcal infections and adult with risk factors. Med. Mal. Infect., 2012, 42 (10), 517-24.
36. Cruickshank, H.C.; Jefferies, J.M.; Clarke, S.C. Lifestyle risk factors for invasive pneumococcal disease: a systematic review. B. M. J. Open, 2014, 4 (6), e005224.
37. O'Brien, K.L.; Wolfson, L.J.; Watt, J.P.; Henkle, E.; Deloria-Knoll, M.; McCall, N.; Lee, E.; Mulholland, K.; Levine, O.S.; Cherian, T. Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Streptococcus pneumonia in children younger than 5 years: global estimates. Lancet, 2009, 374 (9693), 893-902.
38. Kothe, H.; Bauer, T.; Marre, R.; Suttorp, N.; Welte, T.; Dalhoff, K. Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur. Respir. J., 2008, 32, 139-46.
39. El-Solh, A.A.; Sikka, P.; Ramadan, F.; Davies, J. Etiology of severe pneumonia in the very elderly. Am. J. Respir. Crit. Care Med., 2001, 163, 645-51.
40. Restrepo, M.I.; Faverio, P.; Anzueto, A. Long-term prognosis in community-acquired pneumonia. Curr. Opin. Infect. Dis., 2013, 26, 151–8.
41. Huang, S.S. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine, 2011, 29 (18), 3398-412.
42. Welte, T.; Torres, A.; Nathwani, D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax, 2012, 67 (1), 71-9.
43. Wroe, P.C.; Finkelstein, J.A.; Ray, G.T.; Linder, J.A.; Johnson, K.M.; Rifas-Shiman, S.; Moore, M.R.; Huang, S.S. Aging population and future burden of pneumococcal pneumonia in the United States. J. Infect. Dis., 2012, 205 (10), 1589-92.
44. Al-Sherikh, A. Y.; Gowda, K. L.; Mohammed Ali, M.M.; John, J.; Khaled Homoud Mohammed, D.; Chikkabidare Shashidhar, P. Distribution of serotypes and antibiotic susceptibility patterns among invasive pneumococcal diseases in Saudi Arabia. Ann. Lab. Med., 2014, 34 (3), 210-15.
45. Asghar, A.H. Frequency and antibiotic susceptibility of grampositive bacteria in Makkah hospitals. Ann. Saudi Med., 2011, 31 (5), 462-8.
46. Shibl, A.M.; Memish, Z.A.; Al-Kattan, K.M. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA). Vaccine, 2012, 30 (Suppl 6), G32-36.
47. Feldman, C.; Anderson, R. Review: Current and new generation pneumococcal vaccines. J. Infect., 2014 (in press).
48. Pittet, L.F. Pneumococcal vaccines for children: a global public health priority. Clin. Microbiol. Infect., 2012, 5, 25-36.
49. Hackel, M.; Lascols, C.; Bouchillon, S.; Hilton, B.; Morgenstern, D.; Purdy, J. Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations. Vaccine, 2013, 31 (42), 4881-7.
50. Rashid, H.; Khandaker, G.; Booy, R. Vaccination and herd immunity: what more do we know? Curr. Opin. Infect. Dis., 2012, 25 (3), 243-9.
51. Destefano, F.; Pfeifer, D.; Nohynek, H. Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and postlicensure data. World Health Organ., 2008, 86 (5), 373-80.
52. Chaithongwongwatthana, S.; Yamasmit, W.; Limpongsanurak, S.; Lumbiganon, P.; DeSimone, J.A.; Baxter, J.K.; Tolosa, J.E. Pneumococcal vaccination during pregnancy for preventing infant infection. Cochrane Database Syst. Rev., 2012, 7, CD004903.
53. Healy, C.M. Vaccines in pregnant women and research initiatives. Clin. Obstet. Gynecol., 2012, 55 (2), 474-86.
54. Campos-Outcalt D; Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention. Immunization update: the latest ACIP recommendations. J. Fam. Pract.,2014, 63 (3), 137-40.
55. Cho, B.H.; Stoecker, C.; Link-Gelles, R.; Moore, M.R. Costeffectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions. Vaccine, 2013, 31 (50), 6011-21.
56. Gautret, P.; Vu Hai, V.; Sani, S.; Doutchi, M.; Parola, P.; Brouqui, P. Protective measures against acute respiratory symptoms in French pilgrims participating in the Hajj of 2009. J. Travel Med., 2011, 18 (1), 53-5.
57. Khamis, N.K. Epidemiological pattern of diseases and risk behaviors of pilgrims attending mina hospitals, hajj 1427 h (2007 g). J. Egypt. Public Health Assoc., 2008, 83 (1-2),15-33.
58. Al-Jasser, F.S.; Kabbash, I.A.; Almazroa, M.A.; Memish, Z.A. Patterns of diseases and preventive measures among domestic hajjis from Central, Saudi Arabia. Saudi Med. J., 2012, 33(8), 879-86.
59. Ghaznawi, I.; Khalil, M.H. Health hazards and risk factors in the 1406 H (1986 G) Hajj season. Saudi Med J., 1988, 9 (3), 274-82.
60. Meysamie, A.; Ardakani, H.Z.; Razavi, S.M.; Doroodi, T. Comparison of mortality and morbidity rates among Iranian pilgrims in Hajj 2004 and 2005. Saudi Med. J., 2006, 27 (7), 1049-53.
61. El-Sheikh, S.M.; El-Assouli, S.M.; Mohammed K.A.; Albar, M. Bacteria and viruses that cause respiratory tract infections during the pilgrimage (Haj) season in Makkah, Saudi Arabia. Trop. Med. Int. Health, 1998, 3 (3), 205-9.
62. Alzeer, A.; Mashlah, N.; Fakim, N.; Al-Sugair, M.; Al-Hedaithy, S.; Al-Majed, Jamjoom, G. Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah). J. Infect., 1998, 36 (3), 303-6.
63. Asghar, A.H.; Ashshi, A.M.; Azhar, E.I.; Bukhari, S.Z.; Zafar, T.A.; Momenah, A.M. Profile of bacterial pneumonia during Hajj. Indian J. Med. Res., 2011, 133, 510-3.
64. Memish, Z.A.; Almasri, M.; Turkestani, A.; Al Shangiti, A.M.; Yezli, S. Etiology of severe community-acquired pneumonia during Hajj-part of the MERS-CoV surveillance program. Int. J. Infect. Dis., 2014, 25C, 186-90.
65. Mandourah, Y.; Ocheltree, A.; Al Radi, A.; Fowler, R. The epidemiology of Hajj-related critical illness: lessons for deployment of temporary critical care services*. Crit. Care Med., 2012, 40 (3), 829-34.
66. Benkouiten, S.; Gautret, P.; Belhouchat, K.; Drali, T.; Salez, N.; Memish, Z.A.; Al Masri, M.; Fournier, P.E.; Brouqui, P. Acquisition of Streptococcus pneumoniae carriage inpilgrims during the 2012 Hajj. Clin. Infect. Dis., 2014, 58 (4), e106-9.
67. Baharoon, S.; Al-Jahdali, H.; Al Hashmi, J.; Memish, Z.A.; Ahmed, Q.A. Severe sepsis and septic shock at the Hajj: etiologies and outcomes. Travel Med. Infect. Dis., 2009, 7 (4), 247-52.
68. Asghar, A.H. Frequency and antimicrobial susceptibility patterns of bacterial pathogens isolated from septicemic patients in Makkah hospitals. Saudi Med. J., 2006, 27 (3), 361-7.
69. Azeem, M.; Tashani, M.; Barasheed, O.; Heron, L.; Hill-Cawthorne, G.A.; Haworth, E.; Dwyer, E.; Rashid, H.; Booy, R.; on behalf of the Hajj Research Team. Knowledge, attitude and practice (KAP) survey concerning antimicrobial use among Australian Hajj pilgrims. I D-DT, 2014 (in press).
70. Memish, Z.A.; Assiri, A.M.; Hussain, R.; Alomar, I.; Stephens, G. Detection of respiratory viruses among pilgrims in Saudi Arabia during the time of a declared influenza A(H1N1) pandemic. J. Travel Med., 2012, 19 (1), 15-21.
71. Benkouiten, S.; Charrel, R.; Belhouchat, K.; Drali, T.; Salez, N.; Nougairede, A.; Zandotti, C.; Memish, Z.A.; al Masri, M.; Gaillard, C.; Parola, P.; Brouqui, P.; Gautret P. Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage. Clin. Infect. Dis., 2013, 57 (7), 992-1000.
72. Ghouri, N.; Atcha, M.; Sheikh, A. Influence of Islam on smoking among Muslims. B. M. J., 2006, 332 (7536), 291-4.
73. van der Maarel-Wierink, C.D.; Vanobbergen, J.N.; Bronkhorst, E.M.; Schols, J.M.; de Baat, C. Oral health care and aspiration pneumonia in frail older people: a systematic literature review. Gerodontology, 2013, 30 (1), 3-9.
74. Rabie, T.; Curtis, V. Handwashing and risk of respiratory infections: a quantitative systematic review. Trop. Med. Int. Health, 2006, 11 (3), 258-67.
75. Bos, G. The miswãk, an aspect of dental care in Islam. Med. Hist., 1993, 37 (1), 68-79.
76. Wolter, N.; Tempia, S.; Cohen, C.; Madhi, S.A.; Venter, M.; Moyes, J.; Walaza, S.; Kgokong, B.M.; Groome, M.; du Plessis, M.; Magomani, V.; Pretorius, M.; Hellferscee, O.; Dawood, H.; Kahn, K.; Variava, E.; Klugman, K.P.; von Gottberg, A. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J. Infect. Dis., 2014 (in press).
77. Memish, Z.A.; Al Rabeeah, A.A. Health conditions for travellers to Saudi Arabia for the Umra and pilgrimage to Mecca (Hajj). J. Epidemiol. Glob. Health., 2014, 4 (2), 73-5.
78. Memish, Z.A.; Arabi, Y.M.; Ahmed, Q.A.; Shibl, A.M.; Niederman, M.S.; GCC CAP Working Group. Management and prevention strategies for community-acquired pneumonia in the Gulf Corporation Council. J. Chemother., 2007, Suppl 1, 33-46.
79. Chan, T.C.; Fan-Ngai Hung, I.; Ka-Hay Luk, J.; Chu, L.W.; Hon-Wai Chan, F. Effectiveness of influenza vaccination in institutionalized older adults: a systematic review. J.Am.Med.Dir.Assoc., 2014, 15(3), 226.e1-6.
80. World Health Organization. International Travel and Health. Available from: http://www.who.int/entity/ith/en/ (accessed 13th July, 2014).
81. Centers for Disease Control and Prevention (CDC). CDC Health Information for International Travel 2014. Available from: http://wwwnc.cdc.gov/travel/page/2014-yellow-book-about (accessed 13th July, 2014).
82. Gautret, P.: Bauge, M.: Simon, F.; Benkouiten, S.; Parola, P.; Brouqui, P. Pneumococcal vaccination and Hajj. Int. J. Infect. Dis., 2011, 15 (10), e730.
83. Rashid, H.: Shafi, S.: Haworth, E.; Booy, R. Pneumococcal vaccination in adults. Arch. Intern. Med., 2008, 168 (6), 666-7.
84. Tashani, M.; Barasheed, O.; Azeem, M.; Alfelali, M.; Badahdah, A.M.; Bokhary, H.; Almasri, N.; Alshehri; J.; Matbouly, G.; Kalantan, N.; Heron, L.; Ridda, I.; Haworth, E.; Asghar, A.; Rashid, H.; Booy, R.; on behalf of the Hajj Research Team. Pneumococcal vaccine uptake among Australian Hajj pilgrims in 2011-13. ID-DT, 2014 (in press).
85. Memish, Z.A.; Assiri, A.; Almasri, M.; Alhakeem, R.F.; Turkestani, A.; Al Rabeeah, A.A.; Al-Tawfiq, J.A.; Alzahrani, A.; Azhar, E.; Makhdoom, H.Q.; Hajomar, W.H.; Al-Shangiti, A.M.; Yezli, S. Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J. Infect. Dis., 2014(in press).
86. Mahmoud, E.; Hassan, I.S. Toward reducing the burden of pneumococcal disease in the Gulf States. J. Infect. Public Health, 2014, 7 (3), 245-6.
87. Paterson, F.W.N. Letter from Abu Dhabi Welfare of the Hajj. Br.Med. J., 1980, 280 (6226), 1261-2.
88. Kyriacos, S.; Mroueh, M.; Chahine, R.P.; Khouzam, O. Quality of amoxicillin formulations in some Arab countries. J. Clin. Pharm. Ther., 2008, 33 (4), 375-9.